GlassScriptPhysician profile
Josey Schnaufer
NPI 1306389853
$2,312.24
in general payments reported to CMS, 2019-2025
19 companies · $940 in 2025
The $940 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $480 · 2022: $289 · 2023: $280 · 2024: $323 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818 · Travel and Lodging: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.75 |
| Travel and Lodging | $725.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $474.90 | 2025 | |
| Alliance Medical | $464.78 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $290.45 | 2021-2024 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $231.12 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $159.41 | 2021-2024 | |
| Abbvie INC. | $120.19 | 2021-2024 | |
| Lilly USA, LLC | $113.67 | 2021-2024 | Mounjaro |
| Amgen INC. | $68.49 | 2022-2024 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.27 | 2021-2022 | |
| Astellas Pharma US INC | $50.11 | 2023-2024 | Veozah |
| Eisai INC. | $48.26 | 2021-2022 | |
| Exact Sciences Corporation | $47.00 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $39.62 | 2021 | |
| Janssen Pharmaceuticals, INC | $33.14 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.29 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $24.66 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $20.48 | 2022 | |
| Merck Sharp & Dohme LLC | $18.32 | 2021 | |
| Bausch Health US, LLC | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josey Schnaufer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.